Abingworth LLP

Insider Reports History

Location
London
Signature
/s/ John Heard
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abingworth LLP:

Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class
Common Stock
Shares / value
18,022,602
Estimated value
$657,560,041
Report date
29 Mar 2022
Price
$36.49
Ownership
Indirect
Form 4 holding 10%+ Owner

Sierra Oncology, Inc.

Security class
Common Stock, $0.001 par value
Shares / value
1,314,127
Estimated value
$72,276,985
Report date
31 Jan 2022
Price
$55.00
Ownership
Indirect
Form 4 holding 10%+ Owner

Vera Therapeutics, Inc.

Security class
Class A Common Stock
Shares / value
2,960,231
Estimated value
$53,284,158
Report date
18 May 2021
Price
$18.00
Ownership
Indirect
Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class
Warrant (right to buy)
Shares / value
7,720,000
Estimated value
Report date
29 Mar 2022
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Jasper Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
78,045
Estimated value
Report date
21 Mar 2022
Price
Ownership
Indirect
Underlying class
Voting Common Stock
Underlying amount
Form 4 holding 10%+ Owner

eFFECTOR Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
40,000
Estimated value
Report date
06 Oct 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

SOLENO THERAPEUTICS INC

Security class
Stock Option (right to buy)
Shares / value
31,862
Estimated value
Report date
01 Jun 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Vera Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
9,925
Estimated value
Report date
13 May 2021
Price
Ownership
Indirect
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Sierra Oncology, Inc.

Security class
Series B Warrants (right to buy)
Shares / value
0
Estimated value
Report date
28 Jan 2022
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Abingworth LLP

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .